Insufficient endobronchial ultrasound‐guided transbronchial needle aspiration specimens. When and why? The analysis of criteria and reasons behind the insufficient specimens
Diagnostic Cytopathology · 2024
DOI: 10.1002/dc.25284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2024. Verfasst von Antti Vuorisalo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Fimlab Laboratories, Tampere, Finland. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tampereen Tuberkuloosisäätiö, Pirkanmaan Sairaanhoitopiiri, Väinö ja Laina Kiven Säätiö.
Abstract (Originalsprache)
Background
The classification terminology systems for pulmonary cytology specimens have recently emerged. Inadequate samples, classified as "nondiagnostic," raise challenges in determining the threshold of cell numbers and the risk of malignancy (ROM).
Methods
The study retrospectively reviewed 248 endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) samples: 46 insufficient samples, 60 low cellularity samples, and 142 adequate samples. Characteristics as cellularity, number of benign and malignant cells, and background features were assessed. Receiver operating characteristic curve analysis was performed to establish cell sufficiency thresholds for the diagnosis.
Results
Out of the 248 samples analyzed, 108 were classified as benign, 94 as malignant, and 46 as insufficient. The study found that the cellularity thresholds for diagnosis in cell blocks and cytological samples were ≥50 cells and ≥100 cells, respectively. The thresholds for tumor cell counts were ≥1 − 10 cells for both types of cells, respectively. Considerably, some low cellularity samples were initially classified as insufficient despite meeting the diagnostic thresholds upon revision. The ROM varied across sample categories, with insufficient samples having a ROM of 10.9%, benign samples 15.7%, suspicious samples 92.0%, and malignant samples 100%.
Conclusion
Insufficient EBUS‐TBNA samples raise challenges in diagnosis and management. This study identified the root cause of insufficient samples, including factors related to humans, diagnostic methods, sampling, and laboratory processing. By understanding the root causes, diagnostic recommendations can be developed to improve the diagnostic process. The findings emphasize the importance of standardized classification and terminology systems for clear communication among healthcare professionals and institutions, ultimately improving patient care and enabling quality assurance measures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pathology, Fimlab Laboratories, Tampere, Finland.
- Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Förderung
- Tampereen Tuberkuloosisäätiö
- Pirkanmaan Sairaanhoitopiiri
- Väinö ja Laina Kiven Säätiö
Zitieren
APA
Vuorisalo, A., Huhtala, H., Paavonen, T., & Kholová, I. (2024). Insufficient endobronchial ultrasound‐guided transbronchial needle aspiration specimens. When and why? The analysis of criteria and reasons behind the insufficient specimens. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25284
Vancouver
Vuorisalo A, Huhtala H, Paavonen T, Kholová I. Insufficient endobronchial ultrasound‐guided transbronchial needle aspiration specimens. When and why? The analysis of criteria and reasons behind the insufficient specimens. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25284
BibTeX
@article{Vuorisalo2024,
author = {Vuorisalo, Antti and Huhtala, Heini and Paavonen, Timo and Kholová, Ivana},
title = {Insufficient endobronchial ultrasound‐guided transbronchial needle aspiration specimens. When and why? The analysis of criteria and reasons behind the insufficient specimens},
journal = {Diagnostic Cytopathology},
year = {2024},
doi = {10.1002/dc.25284}
}
EUVIMED